Skip to main content
. Author manuscript; available in PMC: 2014 Nov 13.
Published in final edited form as: Gynecol Oncol. 2013 Jul 6;131(1):42–45. doi: 10.1016/j.ygyno.2013.06.034

Table 2.

Cox proportional hazards models of cancer-specific and overall mortality.

Cancer-specific
survival
Overall survival
Histology
Serous Referent Referent
Carcinosarcoma 1.79 (1.68-1.91)* 1.76 (1.65-1.87)*
Age (years)
<50 Referent Referent
50-64 1.36 (1.29-1.43)* 1.41 (1.34-1.49)*
65-74 1.73 (1.63-1.82)* 1.88 (1.78-1.98)*
≥75 2.39 (2.25-2.53)* 2.77 (2.62-2.93)*
Race
White Referent Referent
Black 1.11 (1.03-1.20)* 1.16 (1.08-1.25)*
Other/unknown 0.96 (0.88-1.03) 0.99 (0.92-1.06)
Year of diagnosis
1988-1990 Referent Referent
1991-1993 0.97 (0.90-1.04) 0.94 (0.88-1.01)
1994-1995 0.90 (0.83-0.98)* 0.87 (0.81-0.94)*
1996-1997 0.89 (0.82-0.96)* 0.85 (0.79-0.92)*
1998-1999 0.90 (0.83-0.97)* 0.85 (0.79-0.92)*
2000-2001 0.89 (0.83-0.96)* 0.85 (0.80-0.91)*
2002-2003 0.82 (0.77-0.89)* 0.79 (0.74-0.85)*
2004-2005 0.81 (0.75-0.87)* 0.78 (0.73-0.84)*
2006-2007 0.76 (0.68-0.84)* 0.73 (0.66-0.80)*
Marital status
Married Referent Referent
Unmarried 1.13 (1.09-1.17)* 1.16 (1.12-1.20)*
Unknown 0.99 (0.88-1.11) 1.02 (0.91-1.13)
SEER registry
Eastern Referent Referent
Midwest 1.15 (1.10-1.21)* 1.14 (1.08-1.19)*
West 1.04 (1.00-1.09) 1.04 (0.99-1.08)
Stage1
I Referent Referent
II 2.59 (2.30-2.92)* 1.91 (1.74-2.11)*
IIIA 4.02 (3.45-4.68)* 2.65 (2.32-3.03)*
IIIB 5.20 (4.57-5.91)* 3.40 (3.04-3.79)*
IIIC 6.56 (5.95-7.23)* 4.26 (3.95-4.59)*
IIINOS 7.06 (6.36-7.84)* 4.59 (4.22-4.99)*
IV 9.18 (8.33-
10.12)*
5.88 (5.45-6.34)*
Unknown 6.25 (5.41-7.22)* 4.19 (3.70-4.75)*
*

P<0.05